High-dose flu vaccine no better than standard-dose in reducing death, CV hospitalization
21 Dec 2020
byRoshini Claire Anthony
Patients with high cardiovascular (CV) risk who received a high-dose trivalent influenza vaccine over three influenza seasons did not have a lower risk of cardiopulmonary hospitalization or death compared with those who received a standard-dose quadrivalent vaccine, according to the INVESTED* trial presented at AHA 2020.
High-dose flu vaccine no better than standard-dose in reducing death, CV hospitalization
21 Dec 2020
